Galapagos | GLPG - Assets


Galapagos reported EUR3.41B in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
argenx SE USD 7.18B 973.07M Jun/2025
AstraZeneca USD 114.07B 382M Dec/2025
Biogen USD 29.44B 232M Dec/2025
Genmab DKK 12.87B 5.85B Dec/2025
Gilead Sciences USD 59.02B 490M Dec/2025
GlaxoSmithKline GBP 61.12B 221M Dec/2025
GRIFOLS EUR 19.71B 141.77M Dec/2025
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Incyte USD 6.96B 627.62M Dec/2025
Merck EUR 51.53B 600M Dec/2025
Neurocrine Biosciences USD 4.63B 365.8M Dec/2025
Novartis USD 110.95B 3.66B Dec/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Sanofi EUR 126.81B 2.99B Dec/2025
UCB EUR 18.16B 971M Dec/2025
Vertex Pharmaceuticals USD 25.64B 780.7M Dec/2025